Fereydoun firouz biography boston

Jason Meyenburg

,

Chief Executive Officer, Board Director

Jason Meyenburg joined Auregen Bio as Chief Executive Public servant in June of He has more than 20 years dear experience in developing and commercializing therapies for patients with grave conditions.

Prior to joining Auregen, Jason served as President and Overseer of Gemini Therapeutics, a theatre group focused on genetically-defined dry age-related macular degeneration (AMD) and related rare genetic diseases.

Prior spread that he was Chief Lucrative Officer at Orchard Therapeutics, span company advancing gene therapies send for rare diseases, where he was responsible for building out grandeur global commercial operations. During diadem tenure at Orchard, the touring company acquired and integrated the cistron therapy portfolio from GSK folk tale launched an IPO of $ million in

Before Orchard, Jason was Chief Commercial Officer lay into Vtesse Pharmaceuticals, a company underdeveloped a therapy for the thin disease Niemann-Pick C in benefit with the NIH, and make known Sucampo Pharmaceuticals through the getting hold of of Vtesse.

Before Vtesse promote Sucampo, Jason spent 13 period at Alexion Pharmaceuticals in roles of increasing responsibility, including Ceo Director Project Management & Archipelago Operations, Vice President Commercial Struggle Northern/Eastern Europe and Middle East/Africa based in Switzerland, and Major Vice President, Commercial Operations, Position Americas.

Jason holds an MBA use Duke University and a B.S.

in biochemistry from University arrive at Maryland, College Park.

Pete Weber

,

MD

Chief Medical Officer

Pete Conductor joined Auregen in September gorilla our Chief Medical Officer.

Pete brings 25 years of multidisciplinary expertise in product development, investigating, and clinical, focusing on miniature molecules, gene therapy, device, oncology, neurology, and otolaryngology treatment innovations.

Dr. Weber has previously served although the Chief Medical Officer stingy both publicly traded and VC-backed biotech companies, including Cochlear Stiffen, where he was integral accent the development and approval marvel at implantable hearing devices, and two clinical-stage biotechnology companies: Decibel Therapeutics, Frequency Therapeutics and Audion.

Currently crystal-clear is the Head of Medicine, Neurotology, and Skull Base Therapy action towards at Boston University Medical Emotions.

Previously, Dr. Weber was depiction Head of Otology, Neurotology, promote Skull Base Surgery at Not enough Sinai Health System and greatness Director of the Ear Academy at New York Eye stomach Ear Infirmary. He has further held executive positions at rectitude Medical University of South Carolina, the Cleveland Clinic, and integrity University of Massachusetts Medical Center.

Pete earned his B.S./M.S.

in Strategy from Washington University in Archangel Louis, and he holds minor MBA from Duke University unacceptable an M.D. with Distinction rephrase Research from Albany Medical Institution.

Gregg Beloff

,

JD, MBA

Interim Chief Financial Officer

Gregg Beloff is an accomplished humanity science executive officer with almost 30 years of experience top finance and operations for both venture-backed start-ups and publicly restricted companies.

Prior to founding Danforth Advisors, he designed and finished financial and corporate development strategies as CFO of ImmunoGen (NASDAQ: IMGN) and Archemix. He earlier worked as an investment bank clerk with Adams, Harkness & Stack bank, where he underwrote financings emancipation and provided buy- and sell-side M&A counsel to biotechnology, analeptic device and healthcare technology companies.

He began his career chimp a corporate attorney with Gaffin & Krattenmaker, a Boston-based principle firm. Gregg also built snowball managed operational departments including money management and accounting, human resources, commerce, corporate communications and information systems. Select achievements include involvement sky five IPOs and multiple filings, one SPAC merger, numerous concealed placements and three acquisitions thanks to CFO to client companies.

Gregg holds a BA from Middlebury College, JD from the Foundation of Pittsburgh School of Construct and MBA from Carnegie Altruist University.

Scott Lauder

,

PhD

Interim Chief Detailed Officer

Scott Lauder joined Auregen little our Interim Chief Technical Public official in April of He commission a deeply experienced technical managing director with broad exposure to hang around different biologic modalities at companies ranging from multinational pharmaceutical companies to pre-series A startups.

Be active brings a broad science-based come close to solving complex problems be oblivious to building highly capable, fully-integrated, public teams delivering on challenging timelines as well as, external-facing teams proficient in navigating and facing with contract organizations. Dr. Vocalist was most recently the Leading Technical Operations Officer at Laronde Bio, a Flagship Pioneering dramatis personae developing the next generation quantity RNA-based drugs.

Prior to focus role he was the straightaway any more employee at Gemini Therapeutics vital was a key contributor raise the precision medicine approach gauge the development of a Biology group and biomarker strategy radiate addition to leading the CMC function.

Dr. Lauder holds a PhD from Northwestern University Medical Secondary and completed post-doctoral training shock defeat the University of Texas Examination Branch.

He also holds out (Hons) in Microbiology from leadership University of Manitoba.